Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC

Condition:   Head and Neck Squamous Cell Carcinoma
Intervention:   Other: MVX-ONCO-1
Sponsor:   Swiss Group for Clinical Cancer Research
Not yet recruiting - verified December 2016

http://ift.tt/2hHzPP1